Tausif Butt
President at Idorsia Pharmaceuticals US, Inc.
Tausif Butt active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Idorsia Pharmaceuticals US, Inc. | President | 04/09/2023 | - |
Career history of Tausif Butt
Former positions of Tausif Butt
| Companies | Position | Start | End |
|---|---|---|---|
| CHEMOCENTRYX, INC. | Chief Operating Officer | 23/02/2021 | 19/10/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 31/12/2018 | 31/12/2020 |
Training of Tausif Butt
| University of Brighton | Undergraduate Degree |
| Imperial College London | Graduate Degree |
Statistics
International
| United Kingdom | 4 |
| United States | 3 |
Operational
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private companies | 2 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
| Idorsia Pharmaceuticals US, Inc. |
- Stock Market
- Insiders
- Tausif Butt
- Experience
